Dermatologic Surgery

<jats:sec>
            <jats:title>BACKGROUND</jats:title>
            <jats:p>Cryolipolysis is an effective, well-tolerated noninvasive subcutaneous fat reduction treatment.</jats:p>
          </jats:sec>
          <jats:sec>
            <jats:title>OBJECTIVE</jats:title>
            <jats:p>Assess participant satisfaction, effectiveness, and safety of a dual-applicator cryolipolysis system that can deliver simultaneous treatments.</jats:p>
          </jats:sec>
          <jats:sec>
            <jats:title>MATERIALS AND METHODS</jats:title>
            <jats:p>Adult participants received treatment to the abdomen/flanks (midsection). Participants could also receive treatment to upper arms, thighs, and submental area. Primary end point was participant satisfaction with midsection results at 12 weeks after final treatment. Secondary end points included independent photography review, participant satisfaction with additional body areas, and overall satisfaction. Exploratory end points included 3D imaging of midsection volumetric changes and assessments at 4 weeks after initial treatment. Safety was monitored throughout.</jats:p>
          </jats:sec>
          <jats:sec>
            <jats:title>RESULTS</jats:title>
            <jats:p>Of 110 treated participants, 75% were female. Mean age and body mass index were 43 years and 25.1 kg/m<jats:sup>2</jats:sup>, respectively. Of 96 evaluable participants, 83.3% (80/96) were “satisfied/very satisfied” with midsection results. Reviewers correctly identified 88.0% (81/92) of baseline versus 12 weeks after final treatment midsection images. Mean (SD) subcutaneous fat volume loss was 194.8 (492.3) mL at 12 weeks after final treatment (<jats:italic toggle="yes">p</jats:italic> &lt; .001). Visible improvements were noted at 4 weeks after initial treatment by a majority of physician reviewers and participants. Five (4.5%, 5/110) participants reported 7 treatment-emergent adverse device effects.</jats:p>
          </jats:sec>
          <jats:sec>
            <jats:title>CONCLUSION</jats:title>
            <jats:p>The dual-applicator cryolipolysis system demonstrated high participant satisfaction, effectiveness, and safety.</jats:p>
          </jats:sec>

Fat reduction in the inner thigh using a prototype cryolipolysis applicator

Dermatol Surg

Non-invasive fat reduction of the flanks using a new cryolipolysis applicator and overlapping, two-cycle treatments

Lasers Surg Med

Three-dimensional volumetric quantification of fat loss following cryolipolysis

Safety and efficacy of cryolipolysis for non-invasive reduction of submental fat

Cryolipolysis for noninvasive contouring of the periumbilical abdomen with a nonvacuum conformable-surface applicator

Significant improvement in body contour with multiple cycles of CoolSculpting: results of a prospective study

Dermatol Ther

High participant satisfaction achieved using cryolipolysis for fat reduction of the abdomen and flanks

Aesthet Surg J

Patient satisfaction, recommendation rate, and patient comfort with an FDA-cleared cryolipolysis system

Aesthet Surg J Open Forum

Global expert opinion on cryolipolysis treatment recommendations and considerations: a modified Delphi study

Cryolipolysis is an effective, well-tolerated noninvasive subcutaneous fat reduction treatment.
Assess participant satisfaction, effectiveness, and safety of a dual-applicator cryolipolysis system that can deliver simultaneous treatments.
Adult participants received treatment to the abdomen/flanks (midsection). Participants could also receive treatment to upper arms, thighs, and submental area. Primary end point was participant satisfaction with midsection results at 12 weeks after final treatment. Secondary end points included independent photography review, participant satisfaction with additional body areas, and overall satisfaction. Exploratory end points included 3D imaging of midsection volumetric changes and assessments at 4 weeks after initial treatment. Safety was monitored throughout.
Of 110 treated participants, 75% were female. Mean age and body mass index were 43 years and 25.1 kg/m2, respectively. Of 96 evaluable participants, 83.3% (80/96) were "satisfied/very satisfied" with midsection results. Reviewers correctly identified 88.0% (81/92) of baseline versus 12 weeks after final treatment midsection images. Mean (SD) subcutaneous fat volume loss was 194.8 (492.3) mL at 12 weeks after final treatment (p < .001). Visible improvements were noted at 4 weeks after initial treatment by a majority of physician reviewers and participants. Five (4.5%, 5/110) participants reported 7 treatment-emergent adverse device effects.
The dual-applicator cryolipolysis system demonstrated high participant satisfaction, effectiveness, and safety.

Participant Satisfaction, Effectiveness, and Safety With a Novel Dual-Applicator Cryolipolysis System: A Prospective, Multicountry Study.

Participant Satisfaction, Effectiveness, and Safety With a Novel Dual-Applicator Cryolipolysis System: A Prospective, Multicountry Study

Participant Satisfaction, Effectiveness, and Safety With a Novel Dual-Applicator Cryolipolysis System: A Prospective, Multicountry Study

Clinical Summary

What was studied

Key findings

Study limitations

Clinical implications

Related Questions